NATCO PHARMA LIMITED (INDIA)
Fulvestrant-fulvenat
“Fulvestrant” is the Drug / Molecule content in "Fulvenat". Fulvestrant belongs to a class of medications called an anti-estrogen hormone antagonist. Fulvestrant works by blocking the receptors and this prevents estrogen from reaching the cancer cells. This slows the growth of the cancer.
Indication
Fulvenat is used for the treatment of estrogen-related breast cancers.
Note
Precaution
- Fulvenat is a prescription drug and should be used under proper medical guidance and advice.
- Contraindicated in pregnancy
Strength
250 mg
Packing
Vial
Storage
Cold storage (2-8°C). Protect from light. Store in original carton until time of use.
Was this page helpful?
Related Products
NATCO PHARMA LIMITED (INDIA)
Anastronat
CIPLA LTD. (INDIA)
Anastrozole-armotraz
NATCO PHARMA LIMITED (INDIA)
Xtane
CIPLA LTD. (INDIA).
Armotraz
Most Viewed Products
CIPLA LTD. (INDIA)
Abiraterone acetate-xbira
NATCO PHARMA LIMITED (INDIA)
Bendamustine-bendit
CIPLA LTD. (INDIA)
Bicalutamide-cassotide
NATCO PHARMA LIMITED (INDIA)
Bortezomib-bortenat
NATCO PHARMA LIMITED (INDIA)
Erlonat
Biocon Limited
Everolimus-evertor
NATCO PHARMA LIMITED (INDIA)
Exemestane-xtane
NATCO PHARMA LIMITED (INDIA)
Geftinat
NATCO PHARMA LIMITED (INDIA)
Glatiramer acetate-glatimer
NATCO PHARMA LIMITED (INDIA)
Ledipasvir & sofosbuvir-hepcinat lp
NATCO PHARMA LIMITED (INDIA)
Lenalidomide-lenalid
NATCO PHARMA LIMITED (INDIA)
Pomalidomide-pomalid
NATCO PHARMA LIMITED (INDIA)
Sofosbuvir & velpatasvir-velpanat
NATCO PHARMA LIMITED (INDIA)
Sorafenib-sorafenat
CIPLA LTD. (INDIA)